About Cellworks
Cellworks is a Healthcare company based in San Jose (United States) founded in 2005. Biosimulation platform developed for therapeutic design in life sciences. Cellworks has raised $16.52 million across 2 funding rounds. Its Indian entity Cellworks Research India Private Limited reported revenue of ₹23.98 Cr. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include Genuity Science, Codetta and Cellanome; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2005 and based in San Jose, United States, Cellworks operates in the biotechnology sector. A biosimulation platform is provided to the life science industry, utilizing computational modeling to create frameworks for therapeutic development. Responses to FDA-approved cancer therapies are predicted, and personalized cancer therapy recommendations are offered through this platform.
- Headquarters San Jose, United States
- SectorsHealthcare
- Website cellworks.life
- Social LinkedIn X
- Legal Name Cellworks Research India Private Limited
- Date of Incorporation 25 Apr, 2006
- Indian entity revenue₹23.98 Cr
FY 2024 · +15% YoY
- Indian entity net profit₹2.37 Cr
FY 2024 · 10% margin
- Indian entity EBITDA₹3.92 Cr
FY 2024 · 16% margin
- Total Equity Funding$16.52M (USD)
in 2 rounds
- Latest Funding Round$13M (USD), Series B
Dec 2012
Associated legal entities of Cellworks
Cellworks operates through Cellworks Research India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cellworks Research India Private Limited CIN U72900KA2006PTC039107 | Active | 25 Apr 2006 | Bangalore, Karnataka | ₹24.0 Cr | 119 | 2 | View details |
Funding Insights of Cellworks
Cellworks has successfully raised a total of $16.52M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.52M
- Total Rounds 2
- Last Round Series B — $13M
- First Round $3.52M
(Apr 2009)
All 2 funding rounds of Cellworks with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2012 | $13M | Series B | – | – | – |
| Apr 2009 | $3.52M | Series A | – | – | – |
Board of directors of Cellworks Research India Private Limited (Cellworks)
Cellworks Research India Private Limited is the primary company behind Cellworks. The board of Cellworks Research India Private Limited currently have 2 directors; the longest-serving is Girish Chandra, appointed in 2019. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Girish Chandra DIN 08335213 | Director | 16 Jan 2019 | 7 yrs 9 mo | Cellworks Research India Private Limited |
| Yatin Gurudutt Mundkur DIN 10895900 | Additional Director | 04 Jan 2025 | 1 yr 10 mo | Cellworks Research India Private Limited |
People of Cellworks
70 people are tracked at Cellworks (10 in leadership, 9 in board & advisors, 51 in team).
| Name | Role | Group |
|---|---|---|
Michele Macpherson | Chief Business Officer & CFO | Leadership |
Drew Watson | Chief Biostatistician | Leadership |
Ansu Kumar | Chief Scientific Officer | Leadership |
Chinmaya Rath | Strategic Advisor To CEO | Leadership |
James Wingrove | VP, Clinical Services | Leadership |
Shweta Kapoor | Head of Precision Medicine | Leadership |
Michael Castro | Chief Medical Officer | Leadership |
| CEO | Leadership | |
Brian Battey | Chief Operating Officer | Leadership |
Duane Williams | VP, Pharma Services | Leadership |
Bill Rutter | Board Member | Board & advisors |
David Lawrence | Board Member | Board & advisors |
Richard L. Schilsky | Chairman of Advisory Board | Board & advisors |
Allen Lichter | Board Member | Board & advisors |
Lee Newcomer | Board Member | Board & advisors |
aphne A.Haas-Kogan | Advisor | Board & advisors |
Daniel F. Hayes | Advisor | Board & advisors |
Richard Stone | Clinical Advisor | Board & advisors |
Philip Sawyer | Director | Board & advisors |
Ashish Jaishwal | Senior Scientist R&d | Team |
50 more people are available in the full profile.
Complete people profiles for Cellworks
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cellworks
Figures of Cellworks Research India Private Limited, the primary company behind Cellworks, for FY 2024. Revenue was ₹23.98 Cr (+15% year on year). Net profit was ₹2.37 Cr (10% margin). EBITDA was ₹3.92 Cr (16% margin). Revenue has grown at a compounded annual rate of +6% over three years and +9% over five years.
- ₹23.98 CrRevenue · FY 2024 · +15% YoY
- ₹2.37 CrNet profit · 10% margin
- ₹3.92 CrEBITDA · 16% margin
- ₹5 LakhPaid-up capital
- 119Employees (provident fund records)
- +6%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cellworks Research India Private Limited are on its company page.
Detailed financial statements for Cellworks
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Cellworks
3 dated milestones of Cellworks across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Cellworks is founded.
- Funding First funding round of $3.5M.
- Funding Latest funding round, Series B, of $13.0M.
Competitors of Cellworks
Cellworks has 3 listed competitors in our database, 3 of them funded. They include Genuity Science, Codetta and Cellanome.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. | ||
| codettabio.com | 2021 | Morrisville, United States | $27.28M | Omics clinical data is analyzed through an online platform. | ||
| cellanome.com | 2020 | Palo Alto, United States | $42.71M | Developer of the omic data platform for researchers |
Detailed competitors of Cellworks
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cellworks
The website of Cellworks (cellworks.life) receives about 3.1K visits a month.
- Monthly visits3.1K
▼ 23.1% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cellworks (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellworks
Complete news archive for Cellworks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellworks
Cellworks was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Cellworks is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Cellworks is a funded company, having raised a total of $16.52M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.52M, raised on Apr 2009.
The primary company behind Cellworks, Cellworks Research India Private Limited, reported revenue of ₹23.98 Cr for FY 2024, up 15% year on year.
Founded in 2005 and based in San Jose, United States, Cellworks operates in the biotechnology sector. A biosimulation platform is provided to the life science industry, utilizing computational modeling to create frameworks for therapeutic development. Responses to FDA-approved cancer therapies are predicted, and personalized cancer therapy recommendations are offered through this platform.
Cellworks's top competitors include Codetta, Genuity Science and Cellanome.
Cellworks operates through Cellworks Research India Private Limited.
The legal entities of Cellworks currently have 2 directors, including Girish Chandra, Yatin Gurudutt Mundkur.